| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2873443 | The Annals of Thoracic Surgery | 2014 | 7 Pages |
Abstract
Results from this study suggest that conversion to SIR 1 year after lung transplantation improves survival and decreases the development of BOS. Randomized studies with higher number of patients are needed to determine the prophylactic efficacy of sirolimus in preventing the development of BOS.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Vikas Y. MD, Debra MD, Karan BS, Anthony MD, Dao MD, Tammy MD, Shirin MD, Si M. MD,